RPRD1B and cancer: The results demonstrated a strong positive correlation (rho > 0.4) in the expression levels of CREPT and MYC in six cancers, including UVM, UCEC, COAD, SKCM, ACC, and READ, and a moderate correlation (rho > 0.2) in 18 cancers, including PRAD, STAD, GBM, and LUAD, although a weak correlation (rho < 0.2) was observed in other cancers (Fig. S7A).